Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
107
self-reported 51–200 band
Founded
1997
29 years
Legal entities
None matched
Office countries
3
3 addresses
Funding rounds
2
Grant · Aug 2023 · US$ 21.5K
Company type
Privately Held
self-reported
Description
Back in 1997, husband and wife team Hartley and Marree Atkinson hit the road selling products direct to pharmacies. AFT Pharmaceuticals was formed with a big dream in mind.
In Australasia, our product line now extends to over 130 prescription and non-prescription products. We have offices in Singapore, Kuala Lumpur, Sydney and Auckland (our HQ). We export or license our products to over 109 countries. Plus our Orphan Drugs Foundation provides access to lower cost pharmaceuticals for people with rare diseases within South East Asia and the Pacific.
This success has been built on research and development. R&D is more than corporate speak for us. It’s at the heart of what we do, whether it’s developing new products, or improving existing existing ones. It’s also due to the fact that we are close to the market. Because we sell our own products we are constantly looking for changes in health needs and how we can fill gaps that emerge.
Our ideas, our researchers, our specialist drug development programmes, and the international experts we partner with have allowed us to grow year on year. It’s how we’ve managed to forge a place on the world stage in the extremely competitive pharmaceutical industry.
We're proud of our past achievements. We’re ambitious for the future.
Locations
3
Countries with an office address3 addresses on record
Country footprint
Show as table · Offices in 3 countries
| Countries | 3 |
|---|---|
| Primary country | NZ |
All codes: NZ AU MY
Addresses
- NZLevel 1; 129 Hurstmere Rd; Auckland, 0622Primary
- MYA-16-2, Level 16; Menara UOA Bangsar; No. 5m Jalan Bangsar Utama 1, Kuala Lumpur 59100
- AUSuite 301; 113 Wicks Road; North Ryde, Sydney, New South Wales 2113
Grid intelligence Members
Funding
Rounds2
Round typeGrant · non-equity funding
Amount (USD)21,500
Stage rank1
Investors named1
Since last round2 yr 5 mo
Funding
Show as table · 2 funding rounds
| Rounds | 2 |
|---|---|
| Axis | 1997 to 2026 |
| Grant · 3 Aug 2023 | US$ 21.5K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
How many people work at AFT Pharmaceuticals?
107 counted staff profiles at January 2026, inside the self-reported 51–200 band.
Where does AFT Pharmaceuticals have offices?
Three addresses on record across 3 countries. Primary: Level 1, 129 Hurstmere Rd, Auckland 0622.
Has AFT Pharmaceuticals raised funding?
Two rounds. Latest 3 August 2023: grant, US$21,500, investor Callaghan Innovation.
Which companies are listed alongside AFT Pharmaceuticals?
37 profiles list AFT Pharmaceuticals as a peer — 97th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Neuren Pharmaceuticals Limited and New Zealand Pharmaceuticals Limited list it back.